Search Results - "Cunningham, H. S."

Refine Results
  1. 1

    Mutations of the Connexin43 Gap-Junction Gene in Patients with Heart Malformations and Defects of Laterality by Britz-Cunningham, Scott H, Shah, Maithili M, Zuppan, Craig W, Fletcher, William H

    Published in The New England journal of medicine (18-05-1995)
    “…Birth defects are the leading cause of infant mortality in the United States, 1 and heart malformations are present in at least half of infants with such…”
    Get full text
    Journal Article
  2. 2

    The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro by ARMOUR, A, CUNNINGHAM, S. H, GAZE, M. N, WHELDON, T. E, MAIRS, R. J

    Published in British journal of cancer (01-01-1997)
    “…[131I]meta-iodobenzylguanidine ([131I]MIBG) provides a means of selectively delivering radiation to neuroblastoma cells and is a promising addition to the…”
    Get full text
    Journal Article
  3. 3

    Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models by Carlin, S, Cunningham, S H, Boyd, M, McCluskey, A G, Mairs, R J

    Published in Cancer gene therapy (01-12-2000)
    “…To evaluate the potential of the expression of the sodium/iodide symporter (NIS) as a means of targeting radioiodine to tumor cells, we have employed…”
    Get full text
    Journal Article
  4. 4

    Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions by Cunningham, S H, Mairs, R J, Wheldon, T E, Welsh, P C, Vaidyanathan, G, Zalutsky, M R

    Published in British journal of cancer (01-06-1998)
    “…Radiolabelled meta-iodobenzylguanidine (MIBG) is selectively taken up by tumours of neuroendocrine origin, where its cellular localization is believed to be…”
    Get full text
    Journal Article
  5. 5

    No-Carrier-Added Iodine-131-MIBG: Evaluation of a Therapeutic Preparation by Mairs, Robert J, Cunningham, Shona H, Russell, James, Armour, Alison, Owens, Jonathan, McKellar, Keith, Gaze, Mark N

    Published in The Journal of nuclear medicine (1978) (01-06-1995)
    “…Iodine-131-metaiodobenzylguanidine ([131I]MIBG) is a radiopharmaceutical for imaging as well as targeted radiotherapy of neuroblastoma. It is predicted that…”
    Get full text
    Journal Article
  6. 6

    Temporal Variations in U-series Disequilibria in an Active Caldera, Rabaul, Papua New Guinea by Cunningham, H. S., Turner, S. P., Dosseto, A., Patia, H., Eggins, S. M., Arculus, R. J.

    Published in Journal of petrology (01-03-2009)
    “…Intra-caldera eruptions have been speculated to sample the last batches of magma remaining from earlier caldera-forming eruptions. Rabaul Caldera, New Britain,…”
    Get full text
    Journal Article
  7. 7

    Applications of gene transfer to targeted radiotherapy by Mairs, R J, Cunningham, S H, Boyd, M, Carlin, S

    Published in Current pharmaceutical design (01-09-2000)
    “…For targeted radionuclide therapy to succeed as a single modality treatment, schemes must be devised which will enable the deposition in malignant cells of…”
    Get more information
    Journal Article
  8. 8

    A gene therapy/targeted radiotherapy strategy for radiation cell kill by [131I]meta-iodobenzylguanidine by Boyd, M., Mairs, R. J., Cunningham, S. H., Mairs, S. C., McCluskey, A., Livingstone, A., Stevenson, K, Brown, M. M., Wilson, L., Carlin, S., Wheldon, T. E.

    Published in The journal of gene medicine (01-03-2001)
    “…Background Although [131I]meta‐iodobenzylguanidine (MIBG) is currently one of the best agents available for targeted radiotherapy, its use is confined to a few…”
    Get full text
    Journal Article
  9. 9

    ( 210Pb/ 226Ra) variations during the 1994–2001 intracaldera volcanism at Rabaul Caldera by Cunningham, H.S., Turner, S.P., Patia, H., Wysoczanski, R., Nichols, A.R.L., Eggins, S., Dosseto, A.

    “…Determining the timing and source of gas transfer during intermittent intracaldera volcanism can aid in our understanding of degassing in these large systems…”
    Get full text
    Journal Article
  10. 10

    Oxygen cost of increasing tidal volume and diaphragm flattening in obstructive pulmonary disease by Pitcher, W D, Cunningham, H S

    Published in Journal of applied physiology (1985) (01-06-1993)
    “…Hypercapnia is associated with a shallow breathing pattern in patients with severe chronic obstructive pulmonary disease (COPD). We sought to determine the…”
    Get more information
    Journal Article
  11. 11

    Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill by BOYD, Marie, MAIRS, Robert J, MAIRS, Susan C, WILSON, Lesley, LIVINGSTONE, Anne, CUNNINGHAM, Shona H, BROWN, Mary M, QUIGG, Marlynne, KEITH, W. Nicol

    Published in Oncogene (22-11-2001)
    “…One of the most effective ways to kill cancer cells is by treatment of tumours with radiation. However, the administered dose of radiation to the tumour is…”
    Get full text
    Journal Article
  12. 12

    Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine by BOYD, M, CUNNINGHAM, S. H, BROWN, M. M, MAIRS, R. J, WHELDON, T. E

    Published in Gene therapy (01-06-1999)
    “…Meta-iodobenzylguanidine conjugated to 131I-iodine is an effective agent for the targeted radiotherapy of tumors of neural crest origin which express the…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Molecular Targeting with Radionuclides: State of the Science by Britz-Cunningham, Scott H, Adelstein, S. James

    Published in The Journal of nuclear medicine (1978) (01-12-2003)
    “…Inherent in the application of advances in biomedical science to nuclear medicine is the concept of molecular targeting: the in vivo concentration of labeled…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A gene therapy/targeted radiotherapy strategy for radiation cell kill by by Boyd, M, Mairs, R J, Cunningham, S H, Mairs, S C, McCluskey, A, Livingstone, A, Stevenson, K, Brown, M M, Wilson, L, Carlin, S, Wheldon, T E

    Published in The journal of gene medicine (01-03-2001)
    “…Although [131I]meta-iodobenzylguanidine (MIBG) is currently one of the best agents available for targeted radiotherapy, its use is confined to a few neural…”
    Get full text
    Journal Article
  17. 17

    Enabling Interoperable IT-Based Program-Making Tools with AAF and MXF by Cunningham, S. H., Tudor, P. N.

    Published in SMPTE motion imaging journal (01-07-2004)
    “…Many organizations are contemplating the move to new program-making tools based on generic information technology (IT) equipment. There is remarkable consensus…”
    Get full text
    Magazine Article
  18. 18
  19. 19

    Noradrenaline transporter gene transfer for radiation cell kill by super(131)I meta-iodobenzylguanidine by Boyd, M, Cunningham, SH, Brown, M M, Mairs, R J, Wheldon, TE

    Published in Gene therapy (01-06-1999)
    “…Meta-iodobenzylguanidine conjugated to super(131)I-iodine is an effective agent for the targeted radiotherapy of tumors of neural crest origin which express…”
    Get full text
    Journal Article
  20. 20